Intuitive Surgical, Inc. (NASDAQ:ISRG) will release its second quarter earnings report after the closing bell on Thursday, July 16.

Analysts expect the Sunnyvale, California-based company to report quarterly earnings of $2.50 per share, up from $2.19 per share in the year-ago period. The consensus estimate for Intuitive Surgical’s quarterly revenue is $2.82 billion. It reported $2.44 billion last year, according to Benzinga Pro.

On May 28, Intuitive announced the promotion of global senior vice president of Intuitive’s endoluminal business Taylor Patton to chief commercial and marketing officer.

Intuitive Surgical shares fell 1.2% to close at $406.78 on Friday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

  • BMO Capital analyst Vik Chopra initiated coverage on the stock with an Outperform rating and a price target of $518 on July 9, 2026. This analyst has an accuracy rate of 54%.
  • Evercore ISI Group analyst Vijay Kumar maintained an In-Line rating and cut the price target from $480 to $430 on July 6, 2026. This analyst has an accuracy rate of 58%.
  • B of A Securities analyst Travis Steed maintained the stock with a Buy rating and slashed the price target from $650 to $520 on May 18, 2026. This analyst has an accuracy rate of 56%.
  • Barclays analyst Matt Miksic maintained an Overweight rating and cut the price target from $712 to $651 on April 23, 2026. This analyst has an accuracy rate of 62%.
  • Leerink Partners analyst Mike Kratky maintained an Outperform rating and cut the price target from $622 to $573 on April 22, 2026. This analyst has an accuracy rate of 56%.

Considering buying ISRG stock? Here’s what analysts think:

Photo via Shutterstock